Provider Resources

View the provider directory

Clinical Practice Guidelines

The following clinical practice guidelines are intended to support our health care team and serve as resources to ensure our providers have the most up to date, evidence-based information recommended by nationally recognized organizations. American Medical Directors Association – The Society for Post-Acute and Long-Term Care Medicine – the standard care process in the post-acute and long-term care (PA/LTC) setting.

COPD: Global Strategy for the Diagnosis, Management and Prevention of COPD
Diabetes: Standards of Medical Care in Diabetes – 2024
Heart Failure:
- American College of Cardiology (ACC) and American Heart Association (AHA) and (HFSA) Heart Failure Society of America 2017 Focused Update of the 2013 ACCFAHA Guidelines for the Management of Heart Failure
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Hypertension: ACC and American Heart Association (AHA) guidelines for the detection, prevention, management and treatment of high blood pressure
Dementia:
- Alzheimer’s Association Dementia Care Practice Recommendations
- American Psychiatric Association – Practice Guidelines on the use of Antipsychotics to Treat Agitation or Psychosis in Patients with Dementia
Osteoporosis: 2020 Clinical Practice Guidelines for Postmenopausal Osteoporosis
Depression: American Psychiatric Association(APA)(2019). APA Guideline For the Treatment of Depression. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts
Prevention:

Guidelines are provided for informational purposes only and are not meant to direct individual treatment decisions. All patient care and related decisions are the sole responsibility of providers. These guidelines do not dictate or control a provider’s clinical judgement regarding the appropriate treatment of a patient in any given case.

How to fill out the enrollment form

Who can use this form?

People with Medicare who want to join a Medicare Advantage Plan

To join a plan, you must:

Be a United States citizen or be lawfully present in the U.S.
Live in the plan’s service area

Important: To join a Medicare Advantage Plan, you must also have both:

Medicare Part A (Hospital Insurance)
Medicare Part B (Medical Insurance)

When do I use this form?

You can join plan:

Between October 15–December 7 each year (for coverage starting January 1)
Within 3 months of first getting Medicare
In certain situations where you’re allowed to join or switch plans

Visit Medicare.gov to learn more about when you can sign up for a plan.

What do I need to complete this form?

Your Medicare Number (the number on your red, white, and blue Medicare card)
Your permanent address and phone number

Note: You must complete all items in Section 1. The items in Section 2 are optional — you can’t be denied coverage because you don’t fill them out.

Reminders:

If you want to join a plan during fall open enrollment (October 15–December 7), the plan must get your completed form by December 7.
Your plan will send you a bill for the plan’s premium. You can choose to sign up to have your premium payments deducted from your bank account or your monthly Social Security (or Railroad Retirement Board) benefit.

What happens next?

Once they process your request to join, they’ll contact you

How do I get help with this form?

Call Perennial Advantage at 1-844-788-6959 (YTT 711) 1-844-788-6986 (YTT 711).

Or, call Medicare at 1-800-MEDICARE (1-800-633- 4227). TTY users can call 1-877-486-2048.

En español: Llame a Perennial Advantage al 1-844-788-6959 (YTT 711) 1-844-788-6986 (YTT 711) o a Medicare gratis al 1-800-633-4227 y oprima el 2 para asistencia en español y un representante estará disponible para asistirle.

Individuals experiencing homelessness

If you want to join a plan but have no permanent residence, a Post Office Box, an address of a shelter or clinic, or the address where you receive mail (e.g., social security checks) may be considered your permanent residence address.

According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0938-1378. The time required to complete this information is estimated to average 20 minutes per response, including the time to review instructions, search existing data resources, gather the data needed, and complete and review the information collection. If you have any comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Mail Stop C4-26-05, Baltimore, Maryland 21244-1850.

IMPORTANT Do not send this form or any items with your personal information (such as claims, payments, medical records, etc.) to the PRA Reports Clearance Office. Any items we get that aren’t about how to improve this form or its collection burden (outlined in OMB 0938-1378) will be destroyed. It will not be kept, reviewed, or forwarded to the plan. See “What happens next?” on this page to send your completed form to the plan.

We value you as a member and want to share how your benefits will change, starting April 1,2023.Under the Part B Rebatable Drug Coinsurance Adjustment provision, beginning April 1, 2023, coinsurance for Part B rebatable drugs will be reduced, if the drug’s price has increased at a rate faster than the rate of inflation.

CMS will publish the adjusted beneficiary coinsurance for each Part B rebatable drug in the quarterly pricing files posted on the CMS website, as a 0-20% effective coinsurance of the Medicare-approved payment amount.

Part B rebatable drugs may be in either of the categories “Chemotherapy administration services to include chemotherapy/radiation drugs” or “Other drugs covered under Part B of original Medicare” listed in § 422.100(j)(1)(i). The list of Part B rebatable drugs as well as the effective beneficiary coinsurance for those drugs could change each quarter.

For questions about this document, please contact Member Services at 1-844-788-6986 for additional information. (TTY users should call 711). Hours are 8 a.m. to 8 p.m., seven days a week (except Thanksgiving and Christmas) from October 1 through March 31, and Monday to Friday (except holidays) from April 1 through September 30.

June 1, 2023

We value you as a member and want to share how your benefits will change, starting July 1,2023.

Under the Part B Insulin Cost Sharing Cap, beginning July 1, 2023, Insulin furnished under Part B through an item of durable medical equipment covered under section 1861(n) (i.e., a medically necessary traditional insulin pump), is subject to a beneficiary coinsurance cap for a month’s supply of such insulin (that does not exceed $35 and the Medicare Part B deductible does not apply).

For questions about this document, please contact Member Services at 1-844-788-6986 for additional information. (TTY users should call 711). Hours are 8 a.m. to 8 p.m., seven days a week (except Thanksgiving and Christmas) from October 1 through March 31, and Monday to Friday (except holidays) from April 1 through September 30.

We value you as a member and want to share how your benefits will change, starting April 1,2023.Under the Part B Rebatable Drug Coinsurance Adjustment provision, beginning April 1, 2023, coinsurance for Part B rebatable drugs will be reduced, if the drug’s price has increased at a rate faster than the rate of inflation.

CMS will publish the adjusted beneficiary coinsurance for each Part B rebatable drug in the quarterly pricing files posted on the CMS website, as a 0-20% effective coinsurance of the Medicare-approved payment amount.

Part B rebatable drugs may be in either of the categories “Chemotherapy administration services to include chemotherapy/radiation drugs” or “Other drugs covered under Part B of original Medicare” listed in § 422.100(j)(1)(i). The list of Part B rebatable drugs as well as the effective beneficiary coinsurance for those drugs could change each quarter.

For questions about this document, please contact Member Services at 1-844-788-6959 for additional information. (TTY users should call 711). Hours are 8 a.m. to 8 p.m., seven days a week (except Thanksgiving and Christmas) from October 1 through March 31, and Monday to Friday (except holidays) from April 1 through September 30.

June 1, 2023

We value you as a member and want to share how your benefits will change, starting July 1,2023.

Under the Part B Insulin Cost Sharing Cap, beginning July 1, 2023, Insulin furnished under Part B through an item of durable medical equipment covered under section 1861(n) (i.e., a medically necessary traditional insulin pump), is subject to a beneficiary coinsurance cap for a month’s supply of such insulin (that does not exceed $35 and the Medicare Part B deductible does not apply).

For questions about this document, please contact Member Services at 1-844-788-6959 for additional information. (TTY users should call 711). Hours are 8 a.m. to 8 p.m., seven days a week (except Thanksgiving and Christmas) from October 1 through March 31, and Monday to Friday (except holidays) from April 1 through September 30.